1-11 of 11
Martin L. Sos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Report of the First International Symposium on NUT Carcinoma

Christopher A. French, Michael L. Cheng, Glenn J. Hanna, Steven G. DuBois, Nicole G. Chau, Christine L. Hann, Simone Storck, Ravi Salgia, Matteo Trucco, Jennifer Tseng, Anastasios Stathis, Richard Piekarz, Ulrich M. Lauer, Christophe Massard, Kelly Bennett, Shodeinde Coker, Ulrike Tontsch-Grunt, Martin L. Sos, Sida Liao, Catherine J. Wu, Kornelia Polyak, Sarina A. Piha-Paul, Geoffrey I. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (12): 2493–2505.
https://doi.org/10.1158/1078-0432.CCR-22-0591
Published: 13 June 2022
View articletitled, Report of the First International Symposium on NUT Carcinoma
Open the PDF for Report of the First International Symposium on NUT Carcinoma in another window
Journal Articles

Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients

Dennis Plenker, Miriam Bertrand, Adrianus J. de Langen, Richard Riedel, Carina Lorenz, Andreas H. Scheel, Judith Müller, Johannes Brägelmann, Juliane Daßler-Plenker, Carsten Kobe, Thorsten Persigehl, Alexander Kluge, Thomas Wurdinger, Pepijn Schellen, Gunther Hartmann, Tobias Zacherle, Roopika Menon, Erik Thunnissen, Reinhard Büttner, Frank Griesinger, Jürgen Wolf, Lukas Heukamp, Martin L. Sos, Johannes M. Heuckmann
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1337–1343.
https://doi.org/10.1158/1078-0432.CCR-17-3001
Published: 14 March 2018
View articletitled, Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients
Open the PDF for Structural Alterations of MET Trigger Response to MET Kinase Inhibition in Lung Adenocarcinoma Patients in another window
Includes: Supplementary data
Journal Articles

Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer

Florian Malchers, Meryem Ercanoglu, Daniel Schütte, Roberta Castiglione, Verena Tischler, Sebastian Michels, Ilona Dahmen, Johannes Brägelmann, Roopika Menon, Johannes M. Heuckmann, Julie George, Sascha Ansén, Martin L. Sos, Alex Soltermann, Martin Peifer, Jürgen Wolf, Reinhard Büttner, Roman K. Thomas
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (18): 5527–5536.
https://doi.org/10.1158/1078-0432.CCR-17-0478
Published: 14 September 2017
View articletitled, Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer
Open the PDF for Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Resistance Mechanisms to AZD9291 and Rociletinib—Response

Reinhard Büttner, Jürgen Wolf, Roman K. Thomas, Martin L. Sos
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3967–3968.
https://doi.org/10.1158/1078-0432.CCR-17-0948
Published: 13 July 2017
View articletitled, Resistance Mechanisms to AZD9291 and Rociletinib—Response
Open the PDF for Resistance Mechanisms to AZD9291 and Rociletinib—Response in another window
Journal Articles

Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors

Sandra Ortiz-Cuaran, Matthias Scheffler, Dennis Plenker, llona Dahmen, Andreas H. Scheel, Lynnette Fernandez-Cuesta, Lydia Meder, Christine M. Lovly, Thorsten Persigehl, Sabine Merkelbach-Bruse, Marc Bos, Sebastian Michels, Rieke Fischer, Kerstin Albus, Katharina König, Hans-Ulrich Schildhaus, Jana Fassunke, Michaela A. Ihle, Helen Pasternack, Carina Heydt, Christian Becker, Janine Altmüller, Hongbin Ji, Christian Müller, Alexandra Florin, Johannes M. Heuckmann, Peter Nuernberg, Sascha Ansén, Lukas C. Heukamp, Johannes Berg, William Pao, Martin Peifer, Reinhard Buettner, Jürgen Wolf, Roman K. Thomas, Martin L. Sos
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4837–4847.
https://doi.org/10.1158/1078-0432.CCR-15-1915
Published: 02 October 2016
View articletitled, Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
Open the PDF for Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors in another window
Includes: Supplementary data
Journal Articles

Abstract A20: FGFR1-amplified squamous cell lung cancers depend on FGFR1

Martin L. Sos, Roman K. Thomas
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (14_Supplement): A20.
https://doi.org/10.1158/1078-0432.TCMUSA10-A20
Published: 02 February 2016
View articletitled, Abstract A20: FGFR1-amplified squamous cell lung cancers depend on FGFR1
Journal Articles

Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics

David R. Gandara, Peter S. Hammerman, Martin L. Sos, Primo N. Lara, Jr, Fred R. Hirsch
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (10): 2236–2243.
https://doi.org/10.1158/1078-0432.CCR-14-3039
Published: 14 May 2015
View articletitled, Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics
Open the PDF for Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics in another window
Journal Articles

Characteristics of Lung Cancers Harboring NRAS Mutations

Kadoaki Ohashi, Lecia V. Sequist, Maria E. Arcila, Christine M. Lovly, Xi Chen, Charles M. Rudin, Teresa Moran, David Ross Camidge, Cindy L. Vnencak-Jones, Lynne Berry, Yumei Pan, Hidefumi Sasaki, Jeffrey A. Engelman, Edward B. Garon, Steven M. Dubinett, Wilbur A. Franklin, Gregory J. Riely, Martin L. Sos, Mark G. Kris, Dora Dias-Santagata, Marc Ladanyi, Paul A. Bunn, Jr, William Pao
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (9): 2584–2591.
https://doi.org/10.1158/1078-0432.CCR-12-3173
Published: 30 April 2013
View articletitled, Characteristics of Lung Cancers Harboring NRAS Mutations
Open the PDF for Characteristics of Lung Cancers Harboring NRAS Mutations in another window
Includes: Supplementary data
Journal Articles

Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants

Johannes M. Heuckmann, Hyatt Balke-Want, Florian Malchers, Martin Peifer, Martin L. Sos, Mirjam Koker, Lydia Meder, Christine M. Lovly, Lukas C. Heukamp, William Pao, Ralf Küppers, Roman K. Thomas
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (17): 4682–4690.
https://doi.org/10.1158/1078-0432.CCR-11-3260
Published: 30 August 2012
View articletitled, Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants
Open the PDF for Differential Protein Stability and ALK Inhibitor Sensitivity of EML4-ALK Fusion Variants in another window
Includes: Supplementary data
Journal Articles

ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors

Johannes M. Heuckmann, Michael Hölzel, Martin L. Sos, Stefanie Heynck, Hyatt Balke-Want, Mirjam Koker, Martin Peifer, Jonathan Weiss, Christine M. Lovly, Christian Grütter, Daniel Rauh, William Pao, Roman K. Thomas
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (23): 7394–7401.
https://doi.org/10.1158/1078-0432.CCR-11-1648
Published: 30 November 2011
View articletitled, ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors
Open the PDF for ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors in another window
Includes: Supplementary data
Journal Articles

Inhibition of Nuclear Translocation of Nuclear Factor-κB Despite Lack of Functional IκBα Protein Overcomes Multiple Defects in Apoptosis Signaling in Human B-Cell Malignancies

Roman K. Thomas, Martin L. Sos, Thomas Zander, Özlem Mani, Alexey Popov, Daniel Berenbrinker, Sigrun Smola-Hess, Joachim L. Schultze, Jürgen Wolf
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (22): 8186–8194.
https://doi.org/10.1158/1078-0432.CCR-05-0224
Published: 18 November 2005
View articletitled, Inhibition of Nuclear Translocation of Nuclear Factor-κB Despite Lack of Functional IκBα Protein Overcomes Multiple Defects in Apoptosis Signaling in Human B-Cell Malignancies
Open the PDF for Inhibition of Nuclear Translocation of Nuclear Factor-κB Despite Lack of Functional IκBα Protein Overcomes Multiple Defects in Apoptosis Signaling in Human B-Cell Malignancies in another window